Welcome to Rosen Law Firm

Important Information for Cassava Sciences, Inc. Investors

Are you an investor in Cassava Sciences, Inc. (NASDAQ: SAVA)? If so, you’ll want to pay close attention to the upcoming lead plaintiff deadline of February 10, 2025. Rosen Law Firm, a global investor rights law firm, is here to remind purchasers of securities of Cassava Sciences, Inc. of this important deadline.

What You Need to Know

If you purchased Cassava securities between February 7, 2024 and November 24, 2024, you may be eligible for compensation through a contingency fee arrangement. This means that you could receive compensation without having to pay any out of pocket fees or costs.

Don’t miss out on this opportunity to potentially recover losses from your investments in Cassava Sciences, Inc. Act before the lead plaintiff deadline to secure your rights as an investor.

How This May Affect You

As an investor in Cassava Sciences, Inc., this reminder from Rosen Law Firm could have significant implications for your financial standing. By taking action before the lead plaintiff deadline, you may have the chance to recoup any losses incurred during the specified Class Period.

How This May Impact the World

On a broader scale, the outcome of this case could have ripple effects throughout the financial industry. The handling of investor rights and securities regulations may be influenced by the results of this legal action against Cassava Sciences, Inc.

Conclusion

Don’t wait until it’s too late to seek compensation for your investments. Rosen Law Firm is standing by to help you navigate this complex legal process and protect your rights as an investor. Act now to ensure that your finances are secure in the face of potential losses.